Company: GPAC
Filing Date: 2025-12-03
Form Type: 424B4
Source: 0001140361-25-044114
Chunk: 189

Company: General Purpose Acquisition Corp.
Filing Date: 2025-12-03
Form: 424B4
Chunk 189
---
 and alternative energy sectors. Mr. Argyros has extensive experience in SPACs and maritime finance, having previously served as a Director at Stellar Acquisition III Inc. and Nautilus Marine Acquisition Corp., where he played a key role in strategic transactions and corporate development. Earlier in his career, Mr. Argyros was an investment banker at Morgan Stanley, advising clients on mergers and acquisitions and capital markets transactions.

Chele Farley has agreed to serve on our board of directors. Ms. Farley currently serves as a Partner and Managing Director of Mistral Capital International, a middle-market private equity fund that has invested over $1.6 billion since its inception and that she has been a part of since 1995, where she focuses on private equity investments and strategic advisory across a range of sectors. During her tenure at Mistral Capital International, Ms. Farley has completed transactions with Goldman Sachs, Starwood Capital and Royal Dutch Shell. Ms. Farley served as a director of NASDAQ-listed Murphy Canyon Acquisition Corp. from its initial public offering in February 2022 until its merger with NASDAQ-listed Conduit Pharmaceuticals Inc. (now CDT Equity) in September 2023, following which Ms. Farley continues to serve as a Director and also serves as Chair of the Audit Committee of CDT Equity. She is also a member of the Board of Directors of the WordPress Foundation, which supports open-source initiatives and digital literacy worldwide, and a member of the Board of Directors of Palmilla San Jose Inmobiliara, a real estate resort development in Cabo San Lucas. Earlier in her career, Ms. Farley held merchant banking and investment banking roles at UBS Capital and Goldman Sachs, where she advised on capital markets transactions and mergers and acquisitions. Ms. Farley graduated from Stanford University with a B.S. and M.S. in Industrial Engineering.

Warren Hosseinion has agreed to serve on our board of directors. Dr. Hosseinion was a co-founder in 2001 of Apollo Medical Holdings, Inc. (NASDAQ: ASTH) (which changed its name on February 26, 2024 to Astrana Health, Inc.), was a member of its board of directors from July 2008 to March 2019 and served as its Chief Executive Officer from July 2008 to December 2017 and Co-Chief Executive Officer from December 2017 to March 2019. Dr. Hosseinion is also the Chairman of the Board of Voyager Acquisition Corp (NASDAQ